Activities

Neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) are significant drivers of vision loss in the United States, and they put substantial burdens on patients—both from the disease itself and the need for regular...

This online, on-demand virtual symposium brings together experts in dry eye disease (DED). In this educational program, these experts share insights into recent neuromodulation opportunities in DED, as well as emerging mechanisms of action, such as targeting TRPM8 thermoreceptors to...

This online, on-demand virtual symposium brings together renowned experts in Demodex blepharitis. In this educational program, these experts review the diagnosis and management of Demodex blepharitis, including a review of available and investigational therapies. This educational activity is an archive...

This online, on-demand virtual symposium brings together renowned experts in treating major depressive disorder (MDD). In this educational program, these experts discuss managing patients with MDD by reviewing patient scenarios, reflecting on how to handle challenging cases, and integrating relevant...

This educational activity is an archive of the live presentation held on February 12, 2026. For more information about this educational activity, the faculty, and disclosures, please click here. Target Audience This educational activity is directed toward rheumatologists, nurse practitioners,...

Schizophrenia represents a major psychiatric disorder characterized by symptoms that frequently compromise daily functioning and diminish overall quality of life. While effective management can lead to improved patient outcomes, many individuals continue to struggle with persistent or residual symptoms, medication...

Recent findings indicate that hypercortisolism can be an underlying contributor to difficult-to-control type 2 diabetes (T2D), and it may occur with lower cortisol levels than noted in overt Cushing syndrome. In this program, expert faculty discuss new perspectives on the...

Despite the availability of multiple FDA-approved therapies for the management of patients with obesity, there are still many unmet needs in its management. As a result, additional agents are under investigation for the management of obesity. This program will review...

Psoriasis (PsO) is a chronic, systemic inflammatory disease that affects 3% of US adults; it has been increasingly prevalent over the past years. The disorder is often characterized by chronicity, high grade of disability, and related comorbidities. Notably, biologic agents...

In this program, a panel of retina specialists share their insights into the use of newer anti-VEGF agents, which offer the opportunity for extended treatment intervals for the treatment of retinal vein occlusion (RVO), neovascular age-related macular degeneration, and diabetic...